Skip to main content
logo
Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Sep 29, 2026, 11:15 AM EST

Lipella Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
04618--
Market Cap Growth
-99.92%-37.72%-67.07%---
Enterprise Value
-22418--
Last Close Price
0.003.058.1625.04--

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
0.016.8813.1797.63--
PB Ratio
0.001.921.883.85--
P/TBV Ratio
0.001.921.883.85--

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
-4.488.1698.33--

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
0.180.030.040.090.200.72
Net Debt / Equity Ratio
-1.07-1.11-1.00-1.00-1.01-0.59
Net Debt / EBITDA Ratio
0.290.420.67---
Net Debt / FCF Ratio
0.330.541.002.561.459.62
Asset Turnover
0.170.170.090.050.181.79
Quick Ratio
2.893.018.634.445.033.25
Current Ratio
3.243.478.904.925.313.37
Return on Equity (ROE)
-361.77%-198.12%-118.13%-85.18%-197.73%-35.74%
Return on Assets (ROA)
-149.95%-101.59%-62.27%-40.65%-80.69%-6.62%
Return on Capital Employed (ROCE)
-316.90%-264.70%-148.70%-54.30%-114.60%-7.60%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-230725.50%-136.04%-78.02%-14.45%--
FCF Yield
-206741.73%-107.15%-53.46%-10.18%--
Buyback Yield / Dilution
-217.27%-39.69%-47.84%-19.15%-59.91%-2.46%